Aliases & Classifications for Peanut Allergy

About this section

Aliases & Descriptions for Peanut Allergy:

Name: Peanut Allergy 11 13
Allergy to Peanuts 11 66
Peanut Allergic Reaction 11
 
Peanut Hypersensitivity 37
Allergies Peanut 48

Classifications:



External Ids:

Disease Ontology11 DOID:4378
SNOMED-CT60 213021008, 91935009
MeSH37 D021183

Summaries for Peanut Allergy

About this section
Disease Ontology:11 A food allergy that is an allergy or hypersensitivity to dietary substances from peanuts causing an overreaction of the immune system which in a small percentage of people may lead to severe physical symptoms.

MalaCards based summary: Peanut Allergy, also known as allergy to peanuts, is related to asthma and fruit allergy. An important gene associated with Peanut Allergy is FLG (Filaggrin), and among its related pathways are IL-15 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and African trypanosomiasis. Affiliated tissues include testes, brain and liver, and related mouse phenotypes are muscle and digestive/alimentary.

Wikipedia:69 Peanut allergy is a type of food allergy to peanuts. It is different from nut allergies. Physical... more...

Related Diseases for Peanut Allergy

About this section

Diseases related to Peanut Allergy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 165)
idRelated DiseaseScoreTop Affiliating Genes
1asthma27.7CCL22, FLG, HLA-DQB1, HLA-DRB1, IFNG, IL10
2fruit allergy10.7HLA-DQB1, HLA-DRB1
3wolffian duct adenocarcinoma10.7HLA-DQB1, HLA-DRB1
4quinquaud's decalvans folliculitis10.7HLA-DQB1, HLA-DRB1
5parsonage turner syndrome10.7HLA-DQB1, HLA-DRB1
6pediatric systemic lupus erythematosus10.7HLA-DQB1, HLA-DRB1
7myopathy-growth delay-intellectual disability-hypospadias syndrome10.7HLA-DQB1, HLA-DRB1
8vitreoretinochoroidopathy dominant10.7HLA-DQB1, HLA-DRB1
9krieble bixler syndrome10.6HLA-DQB1, HLA-DRB1
10limb dystonia10.6HLA-DQB1, HLA-DRB1
11spondylarthropathy10.6HLA-DQB1, HLA-DRB1
12mitochondrial encephalomyopathy10.6HLA-DQB1, HLA-DRB1
13rheumatic myocarditis10.6HLA-DQB1, HLA-DRB1
14nebulin-related early-onset distal myopathy10.6HLA-DQB1, HLA-DRB1
15autoinflammation, lipodystrophy, and dermatosis syndrome10.6HLA-DQB1, HLA-DRB1
16foster-kennedy syndrome10.6HLA-DQB1, HLA-DRB1
17thrombocytopenia due to platelet alloimmunization10.6HLA-DQB1, HLA-DRB1
18x-linked congenital generalized hypertrichosis10.6HLA-DQB1, HLA-DRB1
19papillary squamous carcinoma10.6FLG, IL13
20ferro-cerebro-cutaneous syndrome10.6HLA-DQB1, IFNG
21oculogyric crisis10.6HLA-DQB1, HLA-DRB1
22mononeuritis of upper limb10.6HLA-DQB1, HLA-DRB1
23nut allergy10.6FLG, IFNG
24hypoxia10.5HLA-DQB1, HLA-DRB1
25spastic paraplegia-paget disease of bone syndrome10.5HLA-DRB1, IL13
26anthracosilicosis10.5HLA-DRB1, IFNG
27liver carcinoma in situ10.5FLG, IFNG
28indian tick typhus10.5IFNG, IL13
29chronic polyneuropathy10.5HLA-DRB1, IFNG
30goat milk allergy10.5IFNG, IL13
31cholesteatoma of middle ear10.5IFNG, IL13
32acute gonococcal salpingitis10.5IFNG, IL13
33duodenal benign neoplasm10.4HLA-DRB1, IFNG
34cirrhotic cardiomyopathy10.4HLA-DQB1, HLA-DRB1
35epidermolysis bullosa simplex superficialis10.4HLA-DQB1, HLA-DRB1
36fibrous histiocytoma10.4HLA-DRB1, IFNG
37achilles bursitis10.4HLA-DQB1, HLA-DRB1
38malignant neoplasm of acoustic nerve10.4IFNG, IL13
39thomsen and becker disease10.4CCL22, IFNG
40buphthalmos10.3IFNG, IL13
41papillary cystadenocarcinoma10.3IL10, IL13
42selective igm deficiency disease10.3HLA-DQB1, IL10
43panuveitis10.3HLA-DRB1, IL10
44cow milk allergy10.3IL10, IL13
45eye accommodation disease10.3IFNG, IL10
46cholera10.3HLA-DRB1, IL10
47thelaziasis10.3IFNG, IL10
48graft-versus-host disease, protection against10.3IFNG, IL10
49pneumoconiosis10.3CD14, IFNG
50spastic monoplegia10.3IL10, IL13

Graphical network of the top 20 diseases related to Peanut Allergy:



Diseases related to peanut allergy

Symptoms for Peanut Allergy

About this section

Drugs & Therapeutics for Peanut Allergy

About this section

Drugs for Peanut Allergy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
NicotinePhase 4101654-11-5942, 89594
Synonyms:
(−
(+)-Nicotine
(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(+-)-Nicotine
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(R,S)-nicotine
(RS)-nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
(±)-nicotine
)-1-Methyl-2-(3-pyridyl)pyrrolidine
)-Nicotine
)-Nicotine solution
1-Methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
1uw6
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-N-Methylpyrrolidine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
36733_FLUKA
36733_RIEDEL
434F7990-3240-4A43-ACEC-E6CC1E495FA0
46343_FLUKA
46343_RIEDEL
54-11-5
AC1L3I79
AC1Q3ZOC
AI3-03424
BB_NC-0777
BIDD:GT0599
BRD-K05395900-322-02-1
Black Leaf
Black Leaf 40
C00745
CCRIS 1637
CHEBI:17688
CHEMBL3
CID89594
CPD000059074
Campbell's Nico-Soap
Caswell No. 597
Commit
D-Nicotine
D03365
DL-tetrahydronicotyrine
Destruxol
Destruxol Orchid Spray
EINECS 200-193-3
ENT 3,424
EPA Pesticide Chemical Code 056702
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
HSDB 1107
Habitrol
Habitrol (TN)
L(-)-nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
 
L-Nicotine
LS-202
MLS001055457
MLS001335905
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Micotine
MolPort-000-744-731
N3876_SIGMA
N5511_FLUKA
N5511_SIGMA
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCT
NICOTINE AND SALTS
NSC 5065
NSC97238
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotina [Italian]
Nicotine
Nicotine (USP)
Nicotine (compounds related to)
Nicotine Alkaloid
Nicotine Patch
Nicotine Polacrilex
Nicotine [BSI:ISO]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotrol
Nicotrol Inhaler
Nicotrol Ns
Nictoine patch
Nikotin
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Ortho N-4 Dust
Ortho N-5 Dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
R)-(+)-Nicotine
RCRA waste no. P075
RCRA waste number P075
SAM002564224
SDCCGMLS-0066911.P001
SMR000059074
Tendust
Transdermal Nicotine
UN1654
a -N-Methylpyrrolidine
a-N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
bmse000105
delta-Nicotine
nicotine
nicotine replacement patch
2glucocorticoidsPhase 4, Phase 2, Phase 34756
3
BudesonidePhase 441151333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide MMX
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
Horacort
 
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
4
FluticasonePhase 4, Phase 2, Phase 361590566-53-3, 80474-14-262924, 22833648
Synonyms:
90566-53-3
AC-456
AC1NSJZT
Asmatil
Axotide
BIDD:GT0819
Brethal
C07815
CHEMBL1201396
CID5311101
Cultivate
Cutivate
D07981
Flixonase
Flixonase Nasal Spray
Flixotide
Flixotide Disk
 
Flixotide Disks
Flixotide Inhaler
Flonase
Flovent
Flovent Diskus
Flovent Rotadisk
Fluinol
Flunase
Flusonal
Fluspiral
Fluticaps
Fluticaps (TN)
Fluticasone (INN)
Fluticasonpropionat Allen
Flutide
Flutivate
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
fluticasone
5ProgestinsPhase 4525
6
ProgesteronePhase 451557-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
7
Histamine PhosphatePhase 2100851-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
 
EINECS 200-118-4
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
8
histaminePhase 2100975614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
9
OmalizumabPhase 1, Phase 2139242138-07-4
Synonyms:
242138-07-4
D05251
Ig gamma-1 chain C region
Omalizumab
 
Omalizumab (USAN/INN)
Omalizumab (genetical recombination)
Omalizumab (genetical recombination) (JAN)
Xolair
Xolair (TN)
10
GlycerolPhase 1, Phase 221056-81-5753
Synonyms:
1,2,3-Trihydroxypropane
1,2,3-propanetriol
1,2,3-trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerin,anhydrous
Glycerine
Glycerinum
Glyceritol
 
Glycerol
Glycerol 85%
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Monoctanoin component D
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
11
KetotifenPhase 22134580-14-8, 34580-13-73827
Synonyms:
10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1)
116655-74-4
34580-13-7
4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one
4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one
4-(1-Methyl-4-piperidylidene)-9-hydrobenzo[a]thiopheno[3,2-d][7]annulen-10-one
4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one
4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one
AB00053575
AC-15945
AC1L1GSZ
AKOS000541268
Alaway (TN)
BAS 00444483
BIDD:GT0509
BPBio1_000575
BRD-K28936863-051-05-8
BRN 3983897
BSPBio_000521
BSPBio_002964
C19H19NOS
CAS-34580-14-8
CHEBI:112957
CHEMBL534
CID3827
D08105
DB00920
DivK1c_000111
EINECS 252-099-7
HC 20-511
HMS2090F16
HSDB 7283
IDI1_000111
KBio1_000111
KBio2_000906
KBio2_003474
KBio2_006042
KBio3_002184
KBioGR_001289
KBioSS_000906
Ketotifen (INN)
Ketotifen Fumarate
 
Ketotifen [INN:BAN]
Ketotifene
Ketotifene [INN-French]
Ketotifene fumarate
Ketotifeno
Ketotifeno [INN-Spanish]
Ketotifenum
Ketotifenum [INN-Latin]
Ketotifin
Ketotiphen
Ketotiphene
L000753
LS-33820
Lopac-K-2628
Lopac0_000706
MolPort-001-933-278
NCGC00015580-01
NCGC00015580-02
NCGC00015580-03
NCGC00015580-09
NCGC00022572-02
NCGC00022572-04
NCGC00022572-05
NINDS_000111
Oprea1_335550
Oprea1_553550
Prestwick0_000371
Prestwick1_000371
Prestwick2_000371
Prestwick3_000371
SPBio_001275
SPBio_002442
STK048448
STOCK1S-14132
Spectrum2_001198
Spectrum3_001382
Spectrum4_000805
Spectrum5_001395
Spectrum_000426
Tocris-0784
UNII-X49220T18G
Zaditor
ketotifen
12
PhenolPhase 145108-95-2996
Synonyms:
Acide carbolique
Acide phenique
Anbesol
Benzenol
Benzophenol
Campho-phenique cold sore gel
Campho-phenique gel
Campho-phenique liquid
Carbolic acid
Carbolic acid liquid
Carbolic oil
Carbolicum acidum
Carbolsaeure
Carbolsaure
Cepastat lozenges
Cuticura pain relieving ointment
Fenol
Fenolo
Fenosmolin
Fenosmoline
Hydroxy-benzene
Hydroxybenzene
IPH
IZAL
Karbolsaeure
Liquefied phenol
Liquid phenol
Liquified phenol
 
Monohydroxy benzene
Monohydroxybenzene
Monophenol
Oxybenzene
PHOH
Paoscle
Phenic
Phenic Acid
Phenic acid
Phenic alcohol
Phenol
Phenol alcohol
Phenol homopolymer
Phenol liquid
Phenol molten
Phenol polymer-bound
Phenol solution
Phenol synthetic
Phenolated water
Phenolated water for disinfection
Phenole
Phenosmolin
Phenyl alcohol
Phenyl hydroxide
Phenylic Acid
Phenylic acid
Phenylic alcohol
Synthetic phenol
Tea polyphenol
13
Cefpodoxime982619-04-3, 80210-62-46335986
Synonyms:
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
80210-62-4
AC1O3S8J
AC1O426G
AC1Q6LP9
BIDD:GT0771
C08114
C15H17N5O6S2
CEFPODOXIME
CHEBI:606443
CHEMBL1672
CID6335986
CID9570848
CPDX
 
CPDX-PR
Cefpodoxim acid
Cefpodoxima
Cefpodoxima [Spanish]
Cefpodoxime (INN)
Cefpodoxime [INN:BAN]
Cefpodoxime proxetil
Cefpodoximum
Cefpodoximum [Latin]
D07650
DB01416
Epoxim
Epoxim (TN)
LS-177540
MolPort-003-845-691
RU 51807
TL8005407
UNII-7R4F94TVGY
14
Resveratrol109501-36-0, 955365-80-724856436, 445154
Synonyms:
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(p-Hydroxystyryl)resorcinol
(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol
(E)-resveratrol
 
3,4',5-Stilbenetriol
3,4',5-Trihydroxystilbene
3,4',5-trihydroxy-stilbene
MK-1775
trans-3,4',5 - Trihydroxystilbene
trans-3,4',5-trihydroxystilbene
trans-Resveratrol
15
Proton pump inhibitors1057
Synonyms:
 
PPIs
16
Nitric Oxide58510102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
17insulin4401
18
Benzocaine17941994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
19ACIDOPHILUSNutraceutical502
20
Vitamin CNutraceutical48850-81-75785, 54670067
Synonyms:
(+)-Sodium L-ascorbate
(+)-ascorbate
(+)-ascorbic acid
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
3-Keto-L-gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
30208-61-8
33034_RIEDEL
33034_SIAL
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AA
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
AR-1J3435
Acid Ascorbic
Acide ascorbique
Acide ascorbique [INN-French]
Acido ascorbico
Acido ascorbico [INN-Spanish]
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
Antiscorbic Vitamin
Antiscorbic vitamin
Antiscorbutic Vitamin
Antiscorbutic factor
Antiscorbutic vitamin
Arco-Cee
Arco-cee
Ascoltin
Ascoltin (TN)
Ascor-B.I.D.
Ascorb
Ascorbajen
Ascorbate
Ascorbic Acid
Ascorbic Acid, Monosodium Salt
Ascorbic acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
BPBio1_000363
BSPBio_000329
C-Level
C-Long
C-Quin
C-Span
C-Vimin
C00072
C6H8O6
CCRIS 57
CE-VI-Sol
CHEBI:29073
CHEMBL196
CID5785
Cantan
Cantaxin
Caswell No. 061B
Catavin C
Ce Lent
Ce lent
Ce-Mi-Lin
Ce-mi-lin
Ce-vi-sol
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-Caps TD
Cee-Caps Td
Cee-Vite
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-Caps TC
Cetane-Caps TD
Cetane-Caps Tc
Cetane-Caps Td
Cetane-caps TC
Cetane-caps TD
Cetebe
 
Cetemican
Cevalin
Cevatine
Cevex
Cevi-Bid
Cevi-bid
Cevimin
Cevital
Cevitamate
Cevitamic Acid
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
Ciamin
Cipca
Citriscorb
Citrovit
Colascor
Concemin
Cortalex
D00018
DB00126
Davitamon C
Dora-C-500
Duoscorb
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
HSDB 818
HiCee
Hicee
Hybrin
IDO-C
Ido-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina Askorbova
Kyselina askorbova
Kyselina askorbova [Czech]
L(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbate
L-(+)-Ascorbic Acid
L-(+)-Ascorbic acid
L-(+)-ascorbic acid
L-3-Ketothreohexuronic acid lactone
L-3-ketothreohexuronic acid
L-Ascorbate
L-Ascorbic Acid
L-Ascorbic acid
L-Ascorbic acid, free radical form
L-Lyxoascorbate
L-Lyxoascorbic Acid
L-Lyxoascorbic acid
L-Threo-ascorbic acid
L-Threoascorbic acid
L-Xyloascorbate
L-Xyloascorbic Acid
L-Xyloascorbic acid
L-ascorbate
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-ascorbic acid
L-threo-hex-2-enono-1,4-lactone
LS-145
Laroscorbine
Lemascorb
Liqui-Cee
Liqui-cee
MLS002153776
Magnesium Ascorbicum
Magnorbin
Meri-C
Meri-c
MolPort-001-792-501
Monodehydroascorbic acid
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
NCI-C54808
NSC 33832
Natrascorb
Natrascorb injectable
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
SMR001233160
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Sodascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100M
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamin- C
Vitamin-?C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
acide ascorbique
acidum ascorbicum
acidum ascorbinicum
antiscorbic vita min
ascor-b.i.d
ascorbate
ascorbic acid
bmse000182
cee-caps td
cevibid
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
gamma-Lactone L-threo-Hex-2-enonate
gamma-Lactone L-threo-Hex-2-enonic acid
l-ascorbic acid
l-threo-hex-1-eofuranos-3-ulose
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
roscorbi c
vitamin C
ácido ascórbico
21tannic acidNutraceutical1794

Interventional clinical trials:

(show top 50)    (show all 95)
idNameStatusNCT IDPhase
1Basophil Activation Test (BAT) Sensitivity in Child Food AllergyRecruitingNCT01966640Phase 4
2Progesterone and Brain Imaging StudyRecruitingNCT01954966Phase 4
3Dietetic Versus Topical Steroids for Pediatric Eosinophilic EsophagitisRecruitingNCT01846962Phase 4
4Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)RecruitingNCT02635776Phase 3
5Peanut Oral Induction Tolerance in Peanut's Allergic TeenagersRecruitingNCT02046083Phase 2, Phase 3
6SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet StudyRecruitingNCT02778867Phase 2, Phase 3
7Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in AdultsActive, not recruitingNCT01274429Phase 2, Phase 3
8Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut AllergyActive, not recruitingNCT02636699Phase 3
9Safety Study of Viaskin Peanut to Treat Peanut AllergyNot yet recruitingNCT02916446Phase 3
10A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut AllergyCompletedNCT01084174Phase 1, Phase 2
11Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut AllergyCompletedNCT00932282Phase 1, Phase 2
12A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy TrialCompletedNCT00580606Phase 1, Phase 2
13Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut AllergyCompletedNCT01675882Phase 2
14Mucosal Immunotherapy for Peanut AllergyCompletedNCT00597675Phase 2
15Epicutaneous Immunotherapy in Peanut Allergy in ChildrenCompletedNCT01197053Phase 2
16Omalizumab in the Treatment of Peanut AllergyCompletedNCT00949078Phase 2
17A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788gCompletedNCT00382148Phase 2
18Xolair Enhances Oral Desensitization in Peanut Allergic PatientsCompletedNCT01290913Phase 1, Phase 2
19Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OITCompletedNCT01987817Phase 2
20Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and ChildrenCompletedNCT01955109Phase 2
21Promoting Tolerance to Peanut in High-Risk ChildrenCompletedNCT00329784Phase 2
22Persistence of Oral Tolerance to PeanutCompletedNCT01366846Phase 2
23Mechanisms of Desensitization During Peanut Oral ImmunotherapyCompletedNCT01814241Phase 2
24Boiled Peanut Oral Immunotherapy for the Treatment of Peanut Allergy: a Pilot StudyRecruitingNCT02149719Phase 2
25The Effect of Extrinsic Factors on Food AllergyRecruitingNCT01429896Phase 2
26FARE Peanut SLIT and Early Tolerance InductionRecruitingNCT02304991Phase 2
27Therapeutic Effect of Chinese Herbal Medicine on Food AllergyRecruitingNCT00602160Phase 2
28E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food AllergyRecruitingNCT02879006Phase 2
29Oral Immunotherapy (OIT) for Peanut AllergyActive, not recruitingNCT00815035Phase 2
30Peanut Epicutaneous Phase II Immunotherapy Clinical TrialActive, not recruitingNCT01904604Phase 2
31Sublingual Immunotherapy for Peanut Allergy and Induction of ToleranceActive, not recruitingNCT01373242Phase 1, Phase 2
32Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut DesensitizationActive, not recruitingNCT01625715Phase 2
33Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral ImmunotherapyActive, not recruitingNCT02402231Phase 2
34Peanut Oral Immunotherapy in ChildrenActive, not recruitingNCT01867671Phase 2
35Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL StudyActive, not recruitingNCT00932828Phase 1, Phase 2
36The Peanut Oral Immunotherapy Study: Safety, Efficacy and DiscoveryActive, not recruitingNCT02103270Phase 2
37Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical TrialActive, not recruitingNCT01781637Phase 1, Phase 2
38Tolerance Following Peanut Oral ImmunotherapyActive, not recruitingNCT01750879Phase 1, Phase 2
39Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using (CPNA) Peanut OIT Safety Follow-On StudyActive, not recruitingNCT02198664Phase 2
40Mechanisms Underlying Peanut Allergic Reactions in TRACE Peanut Study Participants: Extension StudyEnrolling by invitationNCT02665793Phase 2
41Intranasal Diagnostics in Food Allergy: a Feasibility StudyEnrolling by invitationNCT02159833Phase 1, Phase 2
42Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut AllergyNot yet recruitingNCT02920021Phase 2
43The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut AllergySuspendedNCT01897077Phase 1, Phase 2
44A Safety and Efficacy Study of Xolair in Peanut AllergyTerminatedNCT00086606Phase 2
45Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut AllergyWithdrawnNCT01451450Phase 2
46Peanut Allergy Vaccine Study in Healthy and Peanut-allergic AdultsCompletedNCT00850668Phase 1
47HAL-MPE1 First-in-humanCompletedNCT02163018Phase 1
48Safety of Epicutaneous Immunotherapy for the Treatment of Peanut AllergyCompletedNCT01170286Phase 1
49Study of Tolerance to Oral PeanutCompletedNCT01259804Phase 1
50Trichuris Suis Ova in Peanut and Tree Nut AllergyCompletedNCT01070498Phase 1

Search NIH Clinical Center for Peanut Allergy


Cochrane evidence based reviews: peanut hypersensitivity

Genetic Tests for Peanut Allergy

About this section

Anatomical Context for Peanut Allergy

About this section

MalaCards organs/tissues related to Peanut Allergy:

34
Testes, Brain, Liver, T cells, Skin

Animal Models for Peanut Allergy or affiliated genes

About this section

MGI Mouse Phenotypes related to Peanut Allergy:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.8AHR, HLA-DQB1, IFNG, IL10, IL13
2MP:00053818.7AHR, HLA-DQB1, IFNG, IL10, IL13
3MP:00053888.0AHR, CD14, HLA-DQB1, IFNG, IL10, IL13

Publications for Peanut Allergy

About this section

Articles related to Peanut Allergy:

(show top 50)    (show all 64)
idTitleAuthorsYear
1
Does Exposing Infants to Peanut Products Influence the Risk of a Peanut Allergy? (27343973)
2016
2
Peanut Allergy: New Developments and Clinical Implications. (27039393)
2016
3
Oral immunotherapy for peanut allergy induces eosinophilic esophagitis: three pediatric case reports. (26888330)
2016
4
A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation. (26904156)
2016
5
Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants: Consensus Communication. (26760846)
2016
6
Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Allergy. (26739409)
2016
7
Oral Immunotherapy for Management of Peanut Allergy in Spanish Children. (27326996)
2016
8
The diagnostic value of component-resolved diagnostics in peanut allergy in children attending a Regional Paediatric Allergology Clinic. (27255511)
2016
9
Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy. (27372563)
2016
10
Effect of Avoidance on Peanut Allergy after Early Peanut Consumption. (26942922)
2016
11
Omalizumab facilitates rapid oral desensitization for peanut allergy. (27609658)
2016
12
Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice. (26801740)
2016
13
Cor a 14 is the superior serological marker for hazelnut allergy in children, independent of concomitant peanut allergy. (26666993)
2016
14
The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. (27516216)
2016
15
Safety of epicutaneous immunotherapy for the treatment of peanut allergy: AA phase 1 study using the Viaskin patch. (26920463)
2016
16
Introduction of peanuts in younger siblings of children with peanut allergy: a prospective, double-blinded assessment of risk, of diagnostic tests, and an analysis of patient preferences. (27291651)
2016
17
A humanized mouse model of anaphylactic peanut allergy. (27417025)
2016
18
Clinical Significance of Component Allergens in Fagales Pollen-Sensitized Peanut Allergy in Korea. (27582401)
2016
19
Low dose immunotherapy in very young children to treat peanut allergy. (27599211)
2016
20
Component-Resolved Diagnosis of Peanut Allergy and Its Possible Origins of Sensitization in China. (27240834)
2016
21
Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy. (27464222)
2016
22
Prevalence and factors associated to peanut allergy in Mexican school children. (27475774)
2016
23
Author response to Marrs etA al., Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal. (26769643)
2015
24
The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. (26522257)
2015
25
Peanut allergy as a trigger for the deterioration of atopic dermatitis and precursor of staphylococcal and herpetic associated infections - case report. (26403117)
2015
26
Early introduction of peanut to infants at high allergic risk can reduce peanut allergy at age 5 years. (26385490)
2015
27
Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal. (26769642)
2015
28
Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy. (25765158)
2015
29
Urgent information on peanut allergy: New evidence from the LEAP study. (26775304)
2015
30
Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. (25282568)
2014
31
IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy. (25112699)
2014
32
HLA-DQB1*02 and DQB1*06:03P are associated with peanut allergy. (23443026)
2013
33
Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status. (23684069)
2013
34
Putative peanut allergy-induced urticaria in a dog. (23633716)
2012
35
Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. (21804081)
2011
36
Association of genetic variants of CD14 with peanut allergy and elevated IgE levels in peanut allergic individuals. (21277522)
2011
37
T cell responses to major peanut allergens in children with and without peanut allergy. (20067479)
2010
38
Are plasma IL-10 levels a useful marker of human clinical tolerance in peanut allergy? (20567520)
2010
39
Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. (18234310)
2008
40
Alleviating peanut allergy using genetic engineering: the silencing of the immunodominant allergen Ara h 2 leads to its significant reduction and a decrease in peanut allergenicity. (17784907)
2008
41
Early clinical predictors of remission of peanut allergy in children. (18234313)
2008
42
Clinical pearls and pitfalls: peanut allergy. (15971474)
2005
43
Towards immunotherapy for peanut allergy. (16264338)
2005
44
Relevance of casual contact with peanut butter in children with peanut allergy. (12847496)
2003
45
Serological characteristics of peanut allergy in children. (14616104)
2003
46
Patients with anaphylaxis to pea can have peanut allergy caused by cross-reactive IgE to vicilin (Ara h 1). (12589366)
2003
47
Specific IgE antibodies to peanut in western Sweden--has the occurrence of peanut allergy increased without an increase in consumption? (11421907)
2001
48
The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. (11113829)
2000
49
HLA class II DRB1, DQB1 and DPB1 genotypic associations with peanut allergy: evidence from a family-based and case-control study. (9515587)
1998
50
The production of interferon-gamma in response to a major peanut allergy, Ara h II correlates with serum levels of IgE anti-Ara h II. (8308186)
1994

Variations for Peanut Allergy

About this section

Expression for genes affiliated with Peanut Allergy

About this section
Search GEO for disease gene expression data for Peanut Allergy.

Pathways for genes affiliated with Peanut Allergy

About this section

Pathways related to Peanut Allergy according to GeneCards Suite gene sharing:

(show all 26)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.6IFNG, IL10
29.6IFNG, IL10
3
Show member pathways
9.6AHR, FLG
4
Show member pathways
9.3IFNG, IL10, IL13
5
Show member pathways
9.3IFNG, IL10, IL13
69.3IFNG, IL10, IL13
79.2CD14, IL10
89.2CCL22, IL10, IL13
99.1HLA-DRB1, IFNG, IL13
109.1HLA-DQB1, HLA-DRB1, IFNG
119.0HLA-DQB1, HLA-DRB1, IL10
12
Show member pathways
8.8CD14, IFNG, IL10
138.8CD14, IFNG, IL10
148.8CD14, IFNG, IL10
158.8CD14, IFNG, IL10
168.8CCL22, IFNG, IL10, IL13
17
Show member pathways
8.8CCL22, IFNG, IL10, IL13
188.8AHR, IFNG, IL10, IL13
19
Show member pathways
8.7HLA-DQB1, HLA-DRB1, IFNG, IL13
208.7HLA-DRB1, IFNG, IL10, IL13
218.6CD14, HLA-DQB1, HLA-DRB1
22
Show member pathways
8.6HLA-DQB1, HLA-DRB1, IFNG, IL10
23
Show member pathways
8.6HLA-DQB1, HLA-DRB1, IFNG, IL10
248.6HLA-DQB1, HLA-DRB1, IFNG, IL10
25
Show member pathways
8.3HLA-DQB1, HLA-DRB1, IFNG, IL10, IL13
267.8CD14, HLA-DQB1, HLA-DRB1, IFNG, IL10

GO Terms for genes affiliated with Peanut Allergy

About this section

Cellular components related to Peanut Allergy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:004261310.0HLA-DQB1, HLA-DRB1
2integral component of lumenal side of endoplasmic reticulum membraneGO:007155610.0HLA-DQB1, HLA-DRB1
3clathrin-coated endocytic vesicle membraneGO:003066910.0HLA-DQB1, HLA-DRB1
4transport vesicle membraneGO:00306589.8HLA-DQB1, HLA-DRB1
5external side of plasma membraneGO:00098979.1CD14, IFNG, IL13
6extracellular spaceGO:00056158.0CCL22, CD14, IFNG, IL10, IL13

Biological processes related to Peanut Allergy according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of macrophage activationGO:004303210.3IL10, IL13
2negative regulation of endothelial cell apoptotic processGO:200035210.3IL10, IL13
3positive regulation of MHC class II biosynthetic processGO:004534810.2IFNG, IL10
4defense response to protozoanGO:004283210.2IFNG, IL10
5negative regulation of growth of symbiont in hostGO:004413010.1IFNG, IL10
6positive regulation of cytokine secretionGO:00507159.7CD14, IL10
7response to molecule of bacterial originGO:00022379.6CD14, IL10
8interferon-gamma-mediated signaling pathwayGO:00603339.6HLA-DQB1, HLA-DRB1, IFNG
9T cell receptor signaling pathwayGO:00508529.3HLA-DQB1, HLA-DRB1, IFNG
10cellular response to lipopolysaccharideGO:00712229.2CD14, IFNG, IL10
11cell-cell signalingGO:00072679.1CCL22, IL10, IL13
12immune responseGO:00069558.7CCL22, HLA-DQB1, IL10, IL13
13response to lipopolysaccharideGO:00324968.6CD14, IL10, IL13
14inflammatory responseGO:00069548.4CCL22, CD14, IL10, IL13

Molecular functions related to Peanut Allergy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:00426059.4HLA-DQB1, HLA-DRB1
2cytokine activityGO:00051259.0IFNG, IL10, IL13

Sources for Peanut Allergy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet